← Dashboard

REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE

1 total filings · 0 classes · Active since Dec 2025

4
Expansion Score
Watch Brand

REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 42 (Science & Technology) with 1 filings. The WikiTrademarks Expansion Score is 4/100, low — the brand is focused on defending its existing categories rather than expanding.

USPTO data refreshed June 28, 2026

Own this brand? Claim the profile to add your logo, story, and website.

Sign in to claim

How is REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE filing trademarks, and where is the portfolio expanding?

Filing Velocity (24 Months)

Jul 2024 Jun 2026

Filing Activity by NICE Class

Nice Class Distribution

042 Science & Technology
1

Activity Timeline

No activity recorded yet.

Recent Filings

Serial No. Mark Filing Date Status Classes Owner
99539881 REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE Dec 10, 2025 Registered 042 Science & Technology Sam Shrivastava
See how ChatGPT talks about REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE Beta

Weekly visibility reports showing how ChatGPT mentions REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.

Join waitlist →

FAQ: REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE trademark portfolio

What trademarks does REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE hold?

REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 42 (Science & Technology). The most recent filings are registered to Sam Shrivastava.

How many trademarks does REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE have at the USPTO?

WikiTrademarks tracks 1 USPTO trademark filings attributed to REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE. The brand has been actively filing since December 2025. The count updates daily as new filings are indexed from the USPTO bulk data feed.

In which NICE classes does REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE file most often?

REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE's most active class is NICE Class 42 (Science & Technology), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.

Who owns the REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE trademark?

The most recent filings under the REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE mark are registered to Sam Shrivastava. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.

Is REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE expanding into new categories?

The current WikiTrademarks Expansion Score for REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE is 4 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.

How can I track new REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE trademark filings?

Click the Watch Brand button at the top of this page to add REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.

More on this portfolio: Compare REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE to another owner · Browse all NICE classes · Most valuable brands

Community notes

0 notes
Sign in to add a note

Share what you know about REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE and help the next person researching it.

No notes yet. Be the first to add what you know about REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE.